XML 33 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Net Loss Per Share
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Net Loss Per Share

9.

Net Loss Per Share

Basic and diluted net loss per share was calculated as follows for the three and nine months ended September 30, 2018 and 2017:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Basic net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss (in thousands)

 

$

(122,918

)

 

$

(73,719

)

 

$

(214,494

)

 

$

(200,698

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding

   —basic

 

 

46,706,770

 

 

 

37,470,912

 

 

 

45,866,676

 

 

 

37,367,802

 

Dilutive effect of shares of common stock

   equivalents resulting from common stock

   options and restricted stock units

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding

   —diluted

 

 

46,706,770

 

 

 

37,470,912

 

 

 

45,866,676

 

 

 

37,367,802

 

Net loss per share—basic and diluted

 

$

(2.63

)

 

$

(1.97

)

 

$

(4.68

)

 

$

(5.37

)

 

The following common stock equivalents outstanding as of September 30, 2018 and 2017 were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Stock options

 

 

6,396,175

 

 

 

5,259,925

 

 

 

6,396,175

 

 

 

5,259,925

 

Restricted stock units

 

 

13,800

 

 

 

30,100

 

 

 

13,800

 

 

 

30,100

 

Employee stock purchase plan

 

 

6,481

 

 

 

6,500

 

 

 

6,481

 

 

 

6,500

 

 

 

 

6,416,456

 

 

 

5,296,525

 

 

 

6,416,456

 

 

 

5,296,525

 

 

Stock options and restricted stock units that are outstanding and contain performance-based vesting criteria for which the performance conditions have not been met are excluded from the calculation of common stock equivalents outstanding.